The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
What Happens in the First 8 Weeks of Tirzepatide Treatment?
Tirzepatide, marketed as Mounjaro, is a prescription-only weight management injection approved in the UK for eligible adults. Many people wonder what realistic weight loss looks like in the first 8 weeks of treatment. The truth is that individual results vary significantly, but clinical evidence and NHS guidance provide a useful framework. Most people spend the first 4–8 weeks on low starter doses while their body adjusts, meaning significant weight loss often takes longer than 8 weeks to become noticeable. This guide explains what the NHS says about tirzepatide timelines and what real-world expectations should be.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
NHS Eligibility and Realistic Tirzepatide Timelines
Tirzepatide (Mounjaro) is available through NHS specialist weight management services (tier 3) for adults with a BMI of 30 kg/m² or above, or BMI 27–29.9 with weight-related health conditions like type 2 diabetes, hypertension, or cardiovascular disease. For South Asian, Chinese, Black African, and Black Caribbean adults, lower thresholds apply.
The first 8 weeks are typically the dose adjustment phase. Most people start on 2.5 mg once weekly for weeks 1–4, then escalate to 5 mg for weeks 5–8. These weeks focus on tolerating the injection and managing side effects (nausea, diarrhoea, constipation are common initially), rather than maximum weight loss. Significant weight loss typically accelerates after week 8 when doses are higher and the body has adapted.
NICE guidance and clinical trials show that meaningful weight loss (5–10% body weight) usually takes 12–16 weeks minimum. Eight weeks is too short to judge treatment success. The weekly weight loss injection approach requires patience and lifestyle changes alongside medication.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
NHS vs Private Route and What to Expect
NHS access to tirzepatide requires referral to specialist tier 3 weight management services and can involve waiting lists of several months in many regions. Private prescribing through UK-licensed online providers is faster but costs approximately £150–£200+ per month depending on dose.
Regardless of route, expect: minimal weight change in weeks 1–4 (adjustment phase), modest loss in weeks 5–8 (typically 2–4 kg), and accelerating results from week 9 onwards as doses increase. Use our GLP-1 weight loss calculator to estimate potential weight loss at different tirzepatide doses, and track your progress with our free progress tracker to monitor weekly changes over 8 weeks and beyond. Remember that weight fluctuates daily and weekly targets aren't as important as the overall trend.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Will I lose noticeable weight in 8 weeks on tirzepatide?
Individual results vary, but most people lose 2–4 kg (4–9 lbs) in weeks 1–8, with the first 4 weeks being mainly dose adjustment. Meaningful weight loss (5–10% body weight) typically takes 12–16 weeks. The NHS and clinical trials confirm that 8 weeks is the early phase of treatment.
What is the starting dose of tirzepatide on the NHS?
The starting dose is 2.5 mg once weekly for weeks 1–4, then escalates to 5 mg for weeks 5–8. Further increases happen every 4 weeks if tolerated, up to a maximum of 15 mg once weekly. Dose escalation is managed by your specialist weight management service.
Why is the first 8 weeks mainly about adjustment rather than weight loss?
Low starter doses are used to allow your body to tolerate the injection and manage side effects. Nausea, diarrhoea, and constipation are common in weeks 1–4. Once side effects settle and doses are higher (from week 9+), weight loss typically accelerates.
How can I track tirzepatide weight loss over 8 weeks?
Weigh yourself once or twice per week (same time, same clothes if possible). Weekly weight fluctuates; look at the trend over 4 weeks rather than day-to-day changes. Our free progress tracker helps you log and visualise your weight loss journey over 8 weeks and beyond.
Is tirzepatide available on the NHS without a waiting list?
Availability depends on your local Integrated Care Board (ICB). Some regions have specialist tier 3 weight management services; others have waiting lists of 6–12 months. Your GP can check local availability and make a referral. Private online prescribing is faster but requires payment.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.